Maxime Frélaut

Characteristics and Outcome of SARS-CoV-2 Infection in Cancer Patients

Clémence Basse, Sarah Diakite, Vincent Servois et al. · JNCI Cancer Spectrum · 2020 · 59 citations · Full text

Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer

Adrien Rousseau, Marco Tagliamento, Édouard Auclin et al. · European Journal of Cancer · 2023 · 39 citations · Full text

Medicine, Immune Checkpoint Inhibitors, Immunology +10

Efficacy of molecularly targeted agents given in the randomised trial SHIVA01 according to the ESMO Scale for Clinical Actionability of molecular Targets

Aurélie Moreira, Julien Masliah‐Planchon, Céline Callens et al. · European Journal of Cancer · 2019 · 20 citations · Full text

Drug Targeting, Randomised Trial Shiva01, Pharmacology +8

Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort study

Adrien Rousseau, Stefan Michiels, Noémie Simon‐Tillaux et al. · The Lancet Regional Health - Europe · 2024 · 20 citations · Full text

Fine‐needle aspiration as an alternative to core needle biopsy for tumour molecular profiling in precision oncology: prospective comparative study of next‐generation sequencing in cancer patients included in the SHIVA02 trial

Célia Dupain, Julien Masliah‐Planchon, Céline Gu et al. · Molecular Oncology · 2020 · 19 citations · Full text

Fna Samples, Pathology, High Throughput Sequencing +21